PBSerum: What This Enzyme Product Is and What Is Known

You encounter PBSerum in an article about a double chin, scarring or enzymatic facial contouring. Striking photos may come with promises of gentle action and almost invisible recovery. Before discussing results, find out which specific PBSerum product is involved and how it will be used. The brand covers different ranges: some are intended for topical skin application, while the manufacturer describes a separate HA range as injectable. These are not interchangeable.

In short: PBSerum is a brand of products containing enzymes made through biotechnology. Small studies exist for some injectable enzyme mixtures, but they cannot establish durable benefits or complete safety across every site, formulation and protocol. Evidence for your precise goal, the product's authorised status in the treatment country and the practitioner's competence matter more than a brand name.

Which enzymes are involved, and what can they do?

Enzymes are proteins that accelerate certain biochemical reactions. PBSerum materials refer to collagenases, lipases and either hyaluronidase or lyase, depending on the product range and version. Collagenases can break down particular collagen structures; lipases participate in fat breakdown; enzymes in the hyaluronidase family affect components of the extracellular matrix, including hyaluronic acid. These are biochemical mechanisms, not proof that any given person will lose local fat, eliminate scars or achieve skin tightening.

Fat deposits, fibrosis (abnormally dense connective tissue) and age-related tissue sagging are different problems. Fullness beneath the chin, for example, may reflect subcutaneous fat, jaw anatomy, the position of tissues or several factors together. A fat-targeting intervention will not necessarily address loose skin. Likewise, a proposed improvement in scar texture does not establish that every fold will shrink. Defining the actual aesthetic problem comes first.

Recombinant means an enzyme was produced using a biotechnology system. It does not mean safe for everyone or rule out allergic reactions, tissue damage or sterility concerns. Reactions depend on formulation, concentration, administration route, anatomical site and medical history. Calling enzymes natural dissolvers oversimplifies their behaviour in living tissue.

Is PBSerum always injected? No: the product ranges differ fundamentally

An important detail: the manufacturer says the names HA 1.5 and HA 2.0 and packaging can vary between markets. An article or advertisement mentioning HA Medium does not automatically confirm the contents, registration or indications of a particular box. The injectable product description must not be transferred to topical Plus products, which must never be injected under the skin.

A manufacturer's medical device classification does not establish approval for any particular indication in Armenia, the European Union or the United States. Check actual registration documents, jurisdiction and local rules separately. If documentation is withheld, that alone is a good reason not to proceed with injections. Inability to confirm local registration from available material does not prove that every version is prohibited everywhere.

What has actually been studied, and which questions remain?

A 2024 prospective study of a mixture of lipase, collagenase and hyaluronidase for submental fat (fat beneath the chin) included 10 women. Researchers reported improvements on selected scales after a course of treatments and local reactions during follow-up. These are preliminary findings from a small, non-randomised study without an adequate comparison group and with limited follow-up. It does not prove equal results for abdominal fat, scars or facial laxity, nor can it measure rare complications. This assessment is limited to publications checked in October 2026; the studied mixture and protocol cannot automatically be equated with any currently marketed PBSerum HA Low, Medium or High version.

A separate 2024 paper compiled 229 clinical cases involving pbserum medium across several body sites, focusing on patients' and doctors' satisfaction. Its authors themselves called for better prospective, controlled and comparative studies. The publication disclosed company support and an author's association with the manufacturer. Those links do not erase the observations, but they matter when judging evidence strength. No serious event reported in that series does not mean zero risk for future patients.

A descriptive study published in 2026 followed five women given facial injections of pbserum HA1.5 LOW; its authors reported changes in photographs and skin biopsy samples after 45 days. But there was no control group, participants also underwent a radiofrequency procedure five days later, and two authors worked for the company making and supplying the product. The contribution of the enzymes cannot therefore be separated from the additional procedure or natural variation, rare complications cannot be estimated, and the findings cannot be transferred to other versions or protocols. This adds preliminary evidence, not proof of an established standard of care.

The manufacturer displays before-and-after photographs, satisfaction percentages and safety statements. They are manufacturer claims, not independent guarantees. Ask how many people were studied, for how long, using which exact version, with which comparator, and whether unsuccessful results were counted. An impressive selected photograph cannot tell you how many others saw no worthwhile change.

Is discussing enzymes appropriate for your particular concern?

This is not a list of approved PBSerum medical indications. It illustrates why enzymes for everything is not a credible plan. Any injection proposal requires assessment by a physician able to evaluate contraindications, anatomy, product quality and a response plan for complications. Treatment offered without a precise version, examination and discussion of alternatives cannot meet the standard for informed consent.

Does it hurt, and how visible is the recovery?

For topical cosmetic application, the key concerns are personal tolerance and irritation. Do not assume it offers the same effect or recovery as injections. With injections, discomfort at entry sites, swelling, redness, tenderness and bruising are possible. Visibility depends on body area, formula, technique, tissue response and treatment count. A protocol reported in one study is not a universal recommended schedule for every PBSerum product.

If a work meeting, celebration or journey is coming up, ask not only when work can resume but how the area may look in daylight several days later. Being medically fit to return to activities does not mean bruising and swelling have disappeared. Without good data for a specific formulation and regimen, a single reliable recovery period cannot be given for everyone receiving enzyme injections. Scheduling one just before an important event is unwise.

Restrictions on exercise, massage, heat, makeup, sun exposure and medications depend on the exact procedure and clinician. Do not vigorously massage swelling or apply irritating products in an attempt to make it settle faster. If a provider promises no downtime at all, ask for written guidance about expected temporary reactions and what to do if healing is not typical.

Which risks deserve a clear discussion?

Sterility, incorrect injection depth or position, nerve or blood-vessel injury, inflammation, allergy, unwanted changes in contour and scarring are relevant to injections. In the sources reviewed through October 2026, reliable complication frequencies by PBSerum formulation and body site were not found; do not promise zero risk or copy complication statistics from a different drug. Skill in the relevant anatomy and an emergency response plan are especially important in sensitive injection areas.

The US FDA warns about scarring, infections, deformity and painful nodules following certain unapproved fat-dissolving injections. This is a warning about an intervention category, not evidence that PBSerum itself caused those particular cases. In the United States the FDA identifies Kybella (deoxycholic acid) as its only approved injectable drug to reduce fat under the chin in adults; that US-specific statement does not determine PBSerum's registration status in Armenia.

After any injection, escalating severe pain, rapidly increasing swelling, unusual blanching or darkening of skin, high fever, pus or marked illness require prompt medical assessment. Breathing difficulty, tongue or throat swelling, or sudden visual disturbance requires emergency care. Do not dismiss these signs as expected enzyme activity or wait for a normal post-procedure period to pass.

How is this different from lipolytic injections, fillers and devices?

Shared terminology such as lipolysis does not imply the same mechanism. Deoxycholic acid authorised in a particular country, an injectable lipase-containing enzyme mixture and a topical cream are different products, with different evidence and use rules. Fillers add volume and answer another aesthetic question. Results from devices intended for skin quality or contour depend on their exact model, settings and indication; without direct comparisons, none can simply be called safer or more effective. Significant excess skin may justify a different, sometimes surgical, assessment rather than a series of injections with an unclear goal.

Cellulite and stretch marks have different tissue characteristics and outcomes and should be considered independently; the word remodelling promises no uniform benefit. The broader topic of cellulite and stretch-mark methods is not about one brand. Reviews of PBSerum are a separate question about evaluating others' experiences; here the decision is which product is involved, what evidence supports it and whether it suits you. See the separate guide to cellulite and stretch-mark treatments. See how to assess PBSerum reviews.

Which documentation and answers should you request before treatment?

Ask for the complete product name and version, lot number, expiry date, ingredients, intended administration route and original manufacturer instructions. Request verifiable documentation that the particular product may legally be supplied and used in the country of treatment and its authorised indications. It is European is not a substitute for proof of registration. Also ask about the physician's relevant qualifications and training, who will follow up and where you should seek help if complications occur.

Ask for a measurable aim, such as change to a defined contour rather than general tissue rejuvenation. What is the likelihood of no benefit? How will outcomes be assessed without filters or differences in pose and light? What follow-up duration supports any claimed benefit? What is included in the total fee: consultation, product, follow-up visits and help with an adverse reaction? Asking does not commit you to treatment; it distinguishes planning from a brand presentation.

Examine marketing photos carefully. Head position alters the look of the submental area; weight change, lighting and swelling change a silhouette. Images taken in different poses or without a stated time since treatment cannot be reliable proof. One person's favourable review cannot predict your outcome with your anatomy and health history.

What can you decide right now?

If you only want smoother surface texture, first establish whether the offer concerns a topical cosmetic range, whose expectations and effects are different from those of an injectable treatment. If injections are proposed without the exact label, verifiable regulatory status and a medical examination, declining or postponing is reasonable. If the main issue is a skin disease, postoperative scar or marked sagging, a dermatologist or another relevant specialist may be more useful than choosing a branded product first.

PBSerum should neither be dismissed automatically because studies remain limited nor accepted as a universal risk-free solution. Preliminary clinical evidence exists for particular mixtures and indications, but major questions remain. You have every right to ask for time, compare alternatives and decide that a small cosmetic concern does not call for intervention.